Aspira Women’s Health (AWH) Scheduled to Post Earnings on Wednesday

Aspira Women’s Health (NASDAQ:AWH) will be releasing its earnings data before the market opens on Wednesday, May 15th. Analysts expect Aspira Women’s Health to post earnings of ($0.36) per share for the quarter.

Aspira Women’s Health (NASDAQ:AWH) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.39) by $0.09. The business had revenue of $2.13 million during the quarter, compared to analysts’ expectations of $2.70 million. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. On average, analysts expect Aspira Women’s Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Aspira Women’s Health Price Performance

Shares of AWH opened at $2.98 on Thursday. The stock has a market capitalization of $36.77 million, a price-to-earnings ratio of -0.25 and a beta of 1.57. Aspira Women’s Health has a 1 year low of $2.31 and a 1 year high of $6.75. The business’s 50 day simple moving average is $3.38 and its 200-day simple moving average is $3.87.

Analyst Upgrades and Downgrades

AWH has been the topic of a number of recent research reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $3.30 price target on shares of Aspira Women’s Health in a research note on Wednesday, April 10th. StockNews.com assumed coverage on Aspira Women’s Health in a research report on Thursday. They issued a “hold” rating for the company.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.